Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-01-03 @ 12:08 PM
Study NCT ID:
NCT06079359
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-03
First Post:
2023-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-24
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-06
First Submit QC Date:
None
Study First Post Date:
2023-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-03
Last Update Post Date Type:
ESTIMATED